Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Blood (2019) 134 (Supplement_1): 1840.

https://doi.org/10.1182/blood-2019-125235

Published: 2019

Journal Articles

Quality-Adjusted Time without Symptoms or Toxicity (Q-TWiST) Analysis of Quizartinib Vs Salvage Chemotherapy in Patients with Relapsed/Refractory (R/R) FLT3 -ITD Acute Myeloid Leukemia (AML)

Jorge E. Cortes, MD, Siddhartha Ganguly, MD, Samer K. Khaled, MD, Alwin Krämer, MD, Mark J. Levis, MD, Giovanni Martinelli, MD, Alexander E. Perl, MD, Nigel H. Russell, MD, Marc Botteman, MS, MA, Ruchit Shah, PhD, Linlin Luo, MSc, Zhenming Shun, PhD, Saurabh Ray, PhD

Blood (2019) 134 (Supplement_1): 382.

https://doi.org/10.1182/blood-2019-123554

Published: 2019

Journal Articles

Oncogenic MAF in Co-Operation with IRF4 Confers Extensive Chromatin Re-Arrangement in Plasma Cells and Generates 'Neo-Enhancers' That Regulate Genes Critical for Myeloma Biology

Alexia Katsarou, Nikolaos Trasanidis, Jaime Alvarez-Benayas, Foteini Papaleonidopoulou, Keren Keren, Ioannis V. Kostopoulos, Kanagaraju Ponnusamy, Xiaolin Xiao, Niklas Feldhahn, Irene Roberts, Evdoxia Hatjiharissi, Maria Papaioannou, Ian Sudbery, Aristeidis Chaidos, Valentina S Caputo, Anastasios Karadimitris

Blood (2019) 134 (Supplement_1): 3783.

https://doi.org/10.1182/blood-2019-122371

Published: 2019

Journal Articles

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Scott R. Goldsmith, MD, Mark A. Fiala, BS, Mark A. Schroeder, MD, Tanya M. Wildes, MD, Armin Ghobadi, MD, Ravi Vij, MBBS, Keith E. Stockerl-Goldstein, MD

Blood (2019) 134 (Supplement_1): 4351.

https://doi.org/10.1182/blood-2019-131135

Published: 2019

Journal Articles

Towards a Standardization and Characterization of Clinical Grade Adipose-Derived Stromal Cells

Chiara Cugno, MD, Rita Calzone, Biologist, Giusy Gentilcore, PhD, Heba Sidahmed, Post Doctoral Fellow, Asma Al-Sulaiti, Research Specialist, Moza Al-Khulaifi, Rebecca Mathew, Harshitha Shobha Manjunath, Research Specialist, Sara Tomei, PhD, Ahmed Makki, MD, Jean-Charles Grivel, PhD

Blood (2019) 134 (Supplement_1): 5013.

https://doi.org/10.1182/blood-2019-130385

Published: 2019

Journal Articles

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Michael Daunov, DO, Justin Rondinelli, MD, Sanjay P Ahuja, MD, Nathan Richard Stehouwer, MD

Blood (2019) 134 (Supplement_1): 2428.

https://doi.org/10.1182/blood-2019-130622

Published: 2019

Journal Articles

Using Childhood International Prognostic Scoring in Pediatric Hodgkin Lymphoma Patients Treated with ABVD Can Mitigate Use of Interim PET in LMIC

Reham Khedr, MD, Hanaa Rashad, MD, Asmaa Mohammed Hamoda, MD PhD MSc, Eman Khorshed, PhD, Madeha Elwakeel, PhD, Mohamed Saad, MD, Engy Mohamed, Emad Moussa

Blood (2019) 134 (Supplement_1): 1562.

https://doi.org/10.1182/blood-2019-132195

Published: 2019

Journal Articles

Hispanic Race Is Associated with Increased Risk of Severe Sepsis in 1913 Hospitalizations of Children with AML and Infection

Beth Savage, MSN, ANP, Peter D Cole, MD, Charlotte Thomas-Hawkins, PhD RN, Jerod Stapleton, PhD, Pamela de Cordova, PhD RN-BC, Linda Flynn, PhD RN, FAAN

Blood (2019) 134 (Supplement_1): 1327.

https://doi.org/10.1182/blood-2019-123534

Published: 2019

Journal Articles

Evaluating Thrombocytopenia and Other Biomarkers in Multi-Organ Failure during Sickle Cell Crisis

Krithika Shanmugasundaram, MD, Ixavier Higgins, Fuad A El Rassi, MD, Morgan L. McLemore, MD

Blood (2019) 134 (Supplement_1): 4858.

https://doi.org/10.1182/blood-2019-122439

Published: 2019

Journal Articles

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Hira S Mian, MD, Gregory R Pond, PhD PStat, Sascha A Tuchman, MD, Mark A. Fiala, BS, Tanya M. Wildes, MD MSCI

Blood (2019) 134 (Supplement_1): 4774.

https://doi.org/10.1182/blood-2019-122261

Published: 2019

Journal Articles

Genomic Landscape Including Novel Mutational Drivers in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Blood (2019) 134 (Supplement_1): 919.

https://doi.org/10.1182/blood-2019-123694

Published: 2019

Journal Articles

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507

Adetola A. Kassim, MDMS, Mark C. Walters, MD, Mary Eapen, MBBS, MS, Brianne Allison, MS, Adam M. Mendizabal, MS, Robert A. Brodsky, MD, Michael R. DeBaun, MDMPH

Blood (2019) 134 (Supplement_1): 802.

https://doi.org/10.1182/blood-2019-126321

Published: 2019

Journal Articles

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

Elisabetta Abruzzese, MD, Monica Bocchia, MD PhD, Simona Bernardi, PhD, Malgorzata Monika Trawinska, MD, Donatella Raspadori, PhD, Camilla Zanaglio, PhD, Francesco Bondanini, MD, Anna Sicuranza, PhD, Paola Pacelli, PhD, Michele Malagola, MD, Paolo de Fabritiis, MD

Blood (2018) 132 (Supplement 1): 4244.

https://doi.org/10.1182/blood-2018-99-120363

Published: 2018

Journal Articles

Implementation of a Sickle Cell Disease Screening Initiative in Uganda with HemoTypeSC TM

Ruth Nankanja, Charles Kiyaga, MPhil MBLSM, Mark Geisberg, Erik Serrao, PhD, Stephen Balyegyusa

Blood (2018) 132 (Supplement 1): LBA-3.

https://doi.org/10.1182/blood-2018-120839

Published: 2018

Journal Articles

Identification of Self-Limiting Pediatric Immune Thrombocytopenia at Diagnosis

David Schmidt, MD MSc, Katja Heitink-Pollé, MD PhD, Bart Mertens, PhD, Annemieke G. Laarhoven, MD PhD, Leendert Porcelijn, MD, Barbera Veldhuisen, PhD, C. Ellen van der Schoot, MD PhD, Gestur Vidarsson, PhD, Johanna G van der Bom, MD PhD, Marrie Bruin, MD PhD, Masja De Haas, MD PhD

Blood (2018) 132 (Supplement 1): 1145.

https://doi.org/10.1182/blood-2018-99-116591

Published: 2018

Journal Articles

Longitudinal Sensitivity of the MD Anderson Symptom Inventory for Acute Myeloid Leukemia

Loretta A. Williams, PhD MSN, BSN, BA, Ting Yu Chen, PhD, Dimitrios P. Kontoyiannis, MD, Jessica R. Galloway-Pena, PhD, Pranoti Sahasrabhojane, MS, Samuel A. Shelburne, MD PhD, Tamara E. Lacourt, PhD, Cobi J. Heijnen, PhD, Qiuling Shi, PhD

Blood (2018) 132 (Supplement 1): 4825.

https://doi.org/10.1182/blood-2018-99-113167

Published: 2018

Journal Articles

Oral Regimen for Urine Alkalization in Patients Receiving High Dose Methotrexate during a National Shortage of Intravenous Sodium Bicarbonate

Daniel R Reed, MD, Jeremy M Sen, PharmD, BCOP, Eric J Pierce, MD, Maria C Nicolais, MD, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 2309.

https://doi.org/10.1182/blood-2018-99-112606

Published: 2018

Journal Articles

Delayed Hematologic Recovery in AML Patients after Induction Chemotherapy Is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations

Tracy Murphy, MDFRCP,FRCPath, Jinfeng Zou, PhD, Georgina S Daher-Reyes, MD, Vikas Gupta, MD FRCP, FRCPath, Caroline J McNamara, MBBS, Mark D. Minden, MD PhD, Aaron D Schimmer, MD PhD, Hassan Sibai, MBBS, Karen W.L. Yee, MD, Tracy L. Stockley, PhD FCCMG, FACMG, Suzanne Kamel-Reid, BA, MA, PhD FACMG, Dawn Maze, MDFRCPC,MSc, Scott Bratman, MD PhD, Andre Schuh, Steven M Chan, MD PhD

Blood (2018) 132 (Supplement 1): 992.

https://doi.org/10.1182/blood-2018-99-115518

Published: 2018

Journal Articles

Quality of Life and Symptom Burden Among Patients with Myeloproliferative Neoplasms: Do Symptoms Impact Quality of Life?

Blake T. Langlais, Heidi Kosiorek, MS, Holly Geyer, MD, Robyn M. Scherber, MD, Ruben A Mesa, MD, Amylou C. Dueck, PhD

Blood (2017) 130 (Supplement 1): 3453.

https://doi.org/10.1182/blood.V130.Suppl_1.3453.3453

Published: 2017

Journal Articles

No Association between Age of Transfused Red Cells and 30-Day Mortality in Massively Transfused Patients: Results from the Australian and New Zealand Massive Transfusion Registry

Nicholas Saadah, BS, Erica Wood, Michael Bailey, D. James Cooper, Craig French, Zoe McQuilten

Blood (2017) 130 (Supplement 1): 3728.

https://doi.org/10.1182/blood.V130.Suppl_1.3728.3728

Published: 2017

NARROW

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Quality-Adjusted Time without Symptoms or Toxicity (Q-TWiST) Analysis of Quizartinib Vs Salvage Chemotherapy in Patients with Relapsed/Refractory (R/R) FLT3 -ITD Acute Myeloid Leukemia (AML)

Oncogenic MAF in Co-Operation with IRF4 Confers Extensive Chromatin Re-Arrangement in Plasma Cells and Generates 'Neo-Enhancers' That Regulate Genes Critical for Myeloma Biology

The Ire of IRE1α: Overexpression of IRE1α at Myeloma Diagnosis Is Associated with Decreased Survival While Downregulation of IRE1α Expression Is Predictive of Therapy Resistance

Towards a Standardization and Characterization of Clinical Grade Adipose-Derived Stromal Cells

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Using Childhood International Prognostic Scoring in Pediatric Hodgkin Lymphoma Patients Treated with ABVD Can Mitigate Use of Interim PET in LMIC

Hispanic Race Is Associated with Increased Risk of Severe Sepsis in 1913 Hospitalizations of Children with AML and Infection

Evaluating Thrombocytopenia and Other Biomarkers in Multi-Organ Failure during Sickle Cell Crisis

Geriatric Assessment and Frailty Changes in Older Patients with Newly-Diagnosed Multiple Myeloma Undergoing Treatment

Genomic Landscape Including Novel Mutational Drivers in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease: BMT CTN Protocol 1507

Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR)

Implementation of a Sickle Cell Disease Screening Initiative in Uganda with HemoTypeSC TM

Identification of Self-Limiting Pediatric Immune Thrombocytopenia at Diagnosis

Longitudinal Sensitivity of the MD Anderson Symptom Inventory for Acute Myeloid Leukemia

Oral Regimen for Urine Alkalization in Patients Receiving High Dose Methotrexate during a National Shortage of Intravenous Sodium Bicarbonate

Delayed Hematologic Recovery in AML Patients after Induction Chemotherapy Is Associated with Inferior Relapse-Free Survival and Persistence of Preleukemic Mutations

Quality of Life and Symptom Burden Among Patients with Myeloproliferative Neoplasms: Do Symptoms Impact Quality of Life?

No Association between Age of Transfused Red Cells and 30-Day Mortality in Massively Transfused Patients: Results from the Australian and New Zealand Massive Transfusion Registry

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only